We are live on ! Find out more
AGC

Angelo Gordon & Co Portfolio holdings

AUM $1.06B
1-Year Est. Return 47.95%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+47.95%
3 Year Est. Return
+90.06%
5 Year Est. Return
+125.11%
10 Year Est. Return
+345.29%
AUM
$647M
AUM Growth
-$136M
Cap. Flow
-$261M
Cap. Flow %
-40.34%
Top 10 Hldgs %
68.55%
Holding
92
New
16
Increased
4
Reduced
5
Closed
23

Similar funds

Angelo Gordon & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Angelo Gordon & Co held 92 positions worth $647M, down 17% from $784M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Angelo Gordon & Co withdrew a net $261M in Q4 2019, closing 23 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Utilities at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Angelo Gordon & Co opened a new position in Wright Medical Group Inc worth $10.8M.

  • Angelo Gordon & Co's largest Q4 2019 buy was Wright Medical Group Inc: 355,200 shares worth $10.8M.
  • Angelo Gordon & Co added most to Hovnanian Enterprises in Q4 2019, an estimated $2.11M increase.
  • Angelo Gordon & Co's biggest Q4 2019 reduction was Energy Transfer Partners, cutting an estimated $16.5M.
  • Angelo Gordon & Co fully exited Celgene Corp in Q4 2019, selling an estimated $29.8M.
  • Angelo Gordon & Co's ten largest holdings make up 69% of its $647M portfolio in Q4 2019.
  • Angelo Gordon & Co opened 16 new positions and closed 23 in Q4 2019.
  • Angelo Gordon & Co's portfolio value fell 17% quarter-over-quarter to $647M.

Based on Angelo Gordon & Co's 13F filing for Q4 2019, filed 14 Feb 2020.